共查询到20条相似文献，搜索用时 15 毫秒
1.
王洋;黎晓琴;史思文;王俊;赵书博;吴静;刘红;刘俐惠;代小菊 《中国综合临床》2021,37(05):411-415
目的 探讨聚乙二醇联合西甲硅油对结肠镜检查患者Boston肠道准备量表(boston bowel preparation scale,BBPS)评分及耐受度的影响。 方法 采用病例对照研究方法,选择2018年1月至2019年1月于首都医科大学附属北京世纪坛医院行结肠镜检查的患者220例为研究对象,根据不同肠道准备方案分为对照组和观察组,每组各110例。对照组取4袋复方聚乙二醇电解质散加入凉开水将其配制成4 L溶液进行肠道准备,于内镜检查前6 h开始,每小时服用1 L溶液,最后一次服用时间至结肠镜检查开始时间间隔≤4 h。观察组在对照组基础上内镜检查前4 h口服30 mL西甲硅油乳剂。比较两组研究对象BBPS评分、腔内液体量评分及总分,耐受度及不良反应发生情况。 结果 观察组全结肠评分(7.16±0.61)分、左半结肠评分(2.89±0.62)分、横结肠评分(2.78±0.64)分、右半结肠评分(1.58±0.49)分、肠腔内体液评分为(1.47±0.48)分、总分为(8.84±0.87)分,均高于对照组[分别为(5.13±0.76)、(2.23±0.86)、(2.15±0.76)、(1.14±0.16)、(0.91±0.55),(7.11±1.04)分],两组比较差异均有统计学意义( t值分别为21.854、6.532、6.652、8.957、8.054、13.380, P均<0.05);观察组耐受度(90.00%,99/110)高于对照组(81.81%,90/110),但两组比较差异无统计学意义(χ 2＝3.043, P＝0.081);观察组腹胀发生率(1.82%,2/110)低于对照组(8.18%,9/110),两组比较差异有统计学意义(χ 2＝4.690, P<0.05),两组患者电解质紊乱、恶心呕吐、低血糖或饥饿及心慌胸闷发生率比较差异均无统计学意义( P均>0.05)。 结论 肠道准备中应用聚乙二醇联合西甲硅油能够提高患者肠道清洁度,较单纯使用聚乙二醇不增加患者耐受程度,但减少了患者腹胀的发生。 相似文献
2.
聚乙二醇电解质散在结肠镜检查前肠道准备中的应用 总被引：4，自引：0，他引：4
目的：观察聚乙二醇电解质散清洁肠管的效果和安全性。方法：应用聚乙二醇电解质散进行结肠镜检查前肠道准备，144例病人随机分为A组和B组，A组口服聚乙二醇电解质散，B组口服Niflec。观察服药过程中排便情况，肠腔清洗效果和气泡存在情况，比较服药前后3d大便性状及次数，记录不良反应。结果：143例病人完成研究，其中A组71例，B组72例。两组病人在服药后约1～1.5h开始排便，排便4～8次后即可接受肠镜检查，两组清洁肠道的有效率均为100％。A组2例、B组1例出现轻度恶心、头昏和头痛。两组在排便时间、肠腔清洗效果、服药前后大便性状和次数及不良反应间比较无显著差异。结论：聚乙二醇电解质散应用于结肠镜检查前肠道准备安全有效，准备时间短，不需要饮食限制，值得临床推广应用。 相似文献
3.
4.
Jonathan D Godfrey Robert E Clark Abhishek Choudhary Imran Ashraf Michelle L Matteson Srinivas R Puli Matthew L Bechtold 《World Journal of Meta-Analysis》2013,1(1):10-15
AIM: To evaluate the benefits of low-volume polyethylene glycol (PEG) with ascorbic acid compared to full-dose PEG for colonoscopy preparation.METHODS: MEDLINE, Cochrane Central Register of Controlled Trials and Database of Systematic Reviews, CINAHL, PubMed, and recent abstracts from major conferences were searched (January 2012). Only randomized-controlled trials on adult subjects comparing low-volume PEG (2 L) with ascorbic acid vs full-dose PEG (3 or 4 L) were included. Meta-analysis for the efficacy of low-volume PEG with ascorbic acid and full-dose PEG were analyzed by calculating pooled estimates of number of satisfactory bowel preparations as well as adverse patient events (abdominal pain, nausea, vomiting). Separate analyses were performed for each main outcome by using OR with fixed and random effects models. Heterogeneity was assessed by calculating the I2 measure of inconsistency. RevMan 5.1 was utilized for statistical analysis.RESULTS: The initial search identified 242 articles and trials. Nine studies (n = 2911) met the inclusion criteria and were analyzed for this meta-analysis with mean age range from 53.0 to 59.6 years. All studies were randomized controlled trials on adult patients comparing large-volume PEG solutions (3 or 4 L) with low-volume PEG solutions and ascorbic acid. No statistically significant difference was noted between low-volume PEG with ascorbic acid and full-dose PEG for number of satisfactory bowel preparations (OR 1.07, 95%CI: 0.86-1.33, P = 0.56). No statistically significant difference was noted between low-volume PEG with ascorbic acid and full-dose PEG for abdominal pain (OR 1.09, 95%CI: 0.81-1.48, P = 0.56), nausea (OR 0.70, 95%CI: 0.49-1.00, P = 0.05), or vomiting (OR 0.99, 95%CI: 0.78-1.26, P = 0.95). No publication bias was noted.CONCLUSION: Low-volume PEG with the addition of ascorbic acid demonstrates no statistically significant difference to full-dose PEG for satisfactory bowel preparation and side-effects. 相似文献
5.
Hu Zhang Jing Gong Lin-Song Ma Ting Jiang Heng Zhang 《World Journal of Clinical Cases》2021,9(15):3607-3622
BACKGROUNDAlthough several trials have shown that the addition of antifoaming agents to polyethylene glycol (PEG) can improve bowel preparation, whether PEG plus antifoaming agents have a beneficial role in the detection of benign tumors during colonoscopy has yet to be confirmed. Our aim was to clarify whether adding simethicone to PEG solution could improve the detection of benign colorectal tumors.AIMTo clarify whether adding simethicone to PEG solution could improve the detection of benign colorectal tumors.METHODSThe PubMed, EMBASE, and Cochrane Library databases were searched for articles published prior to September 2019. The outcomes included the detection rates of colorectal adenomas and polyps.RESULTTwenty studies were eligible. Although there was no difference in the colorectal adenoma detection rate (ADR), a significant effect of simethicone for diminutive adenomas (< 10 mm) was revealed in the group taking simethicone. We also found that simethicone could significantly improve the ADR in the proximal colon but did not affect the colorectal polyp detection rate. Furthermore, the subgroup analyses revealed a beneficial effect of simethicone on the ADR among Asians (P = 0.005) and those with an ADR < 25% (P = 0.003). Moreover, it was a significant finding that the low dose simethicone was as effective as the high dose one with respect to the detection of benign colorectal tumors.CONCLUSIONIn summary, the addition of simethicone to PEG might improve the detection of diminutive adenomas in the right colon by colonoscopy in Asia. Low-dose simethicone was recommended for the detection of benign colorectal tumors. However, large clinical trials are necessary to validate our results and determine the ideal dose of simethicone. 相似文献
6.
Hui Pan Xiao-Ling Zheng Chao-Ying Fang Lan-Zai Liu Jian-Su Chen Chao Wang Yu-Dai Chen Jian-Min Huang Yu-Shen Zhou Li-Ping He 《World Journal of Clinical Cases》2022,10(22):7844-7858
BACKGROUNDSplit-dose regimens (SpDs) of 4 L of polyethylene glycol (PEG) have been established as the “gold standard” for bowel preparation; however, its use is limited by the large volumes of fluids required and sleep disturbance associated with night doses. Meanwhile, the same-day single-dose regimens (SSDs) of PEG has been recommended as an alternative; however, its superiority compared to other regimens is a matter of debate.AIMTo compare the efficacy and tolerability between SSDs and large-volume SpDs PEG for bowel preparation.METHODSWe searched MEDLINE/PubMed, the Cochrane Library, RCA, EMBASE and Science Citation Index Expanded for randomized trials comparing (2 L/4 L) SSDs to large-volume (4 L/3 L) SpDs PEG-based regimens, regardless of adjuvant laxative use. The pooled analysis of relative risk ratio and mean difference was calculated for bowel cleanliness, sleep disturbance, willingness to repeat the procedure using the same preparation and adverse effects. A random effects model or fixed-effects model was chosen based on heterogeneity analysis among studies.RESULTSA total of 18 studies were included. There was no statistically significant difference of adequate bowel preparation (relative risk = 0.97; 95%CI: 0.92-1.02) (14 trials), right colon Boston Bowel Preparation Scale (mean difference = 0.00; 95%CI: -0.04, 0.03) (9 trials) and right colon Ottawa Bowel Preparation Scale (mean difference = 0.04; 95%CI: -0.27, 0.34) (5 trials) between (2 L/4 L) SSDs and large-volume (4 L/3 L) SpDs, regardless of adjuvant laxative use. The pooled analysis favored the use of SSDs with less sleep disturbance (relative risk = 0.52; 95%CI: 0.40, 0.68) and lower incidence of abdominal pain (relative risk = 0.75; 95%CI: 0.62, 0.90). During subgroup analysis, patients that received low-volume (2 L) SSDs showed more willingness to repeat the procedure using the same preparation than SpDs (P < 0.05). No significant difference in adverse effects, including nausea, vomiting and bloating, was found between the two arms (P > 0.05).CONCLUSIONRegardless of adjuvant laxative use, the (2 L/4 L) SSD PEG-based arm was considered equal or better than the large-volume (≥ 3 L) SpDs PEG regimen in terms of bowel cleanliness and tolerability. Patients that received low-volume (2 L) SSDs showed more willingness to repeat the procedure using the same preparation due to the low-volume fluid requirement and less sleep disturbance. 相似文献
7.
Hiroyuki Tamaki Teruyo Noda Masahiro Morita Akina Omura Atsushi Kubo Chikara Ogawa Toshihiro Matsunaka Mitsushige Shibatoge 《World Journal of Clinical Cases》2019,7(4):452-465
BACKGROUND A low-volume polyethylene glycol(PEG) solution that combines ascorbic acid with PEG-based electrolyte solution(PEG-ASC) is gaining mainstream acceptance for bowel preparation due to reduced volume and improved taste.Although several reports showed that bowel preparation with PEG-ASC volume lower than 2.0 L with laxative agents could be an alternative to traditional preparation regimen, the cleansing protocols have not been fully investigated.AIM To evaluate the cleansing efficacy of 1.2 L PEG-ASC solution comparing with 2.0 L PEG electrolyte(PEG-ELS) for bowel preparations.METHODS A randomized, single-blinded, open-label, single-center, non-inferiority study was conducted. In total, 312 Japanese adult patients(aged > 18 years) who underwent colonoscopy were enrolled. Patients were randomly allocated to bowel lavage with either 1.2 L of PEG-ASC solution with at least 0.6 L of an additional clear fluid(1.2 L PEG-ASC group) or 2.0 L of PEG-ELS(PEG-ELS group). Then, 48 mg of sennoside was administered at bedtime on the day before colonoscopy, and the designated drug solution was administered at the hospital on the day of colonoscopy. Bowel cleansing was evaluated using the Boston Bowel Preparation Scale(BBPS). The volume of fluid intake and required time for bowel preparation were evaluated. Furthermore, compliance, patient tolerance,and overall acceptability were evaluated using a patient questionnaire, which was assessed using a visual analog scale.RESULTS In total, 291 patients(1.2 L PEG-ASC group, 148; PEG-ELS group, 143) completed the study. There was no significant difference in successful cleansing, defined as a BBPS score ≥ 2 in each segment, between the two groups(1.2 L PEG-ASC group, 91.9%; PEG-ELS group, 90.2%; 95%CI:-0.03-0.09). The required time for bowel preparation was significantly shorter(164.95 min ± 68.95 min vs 202.16 min± 68.69 min, P < 0.001) and the total fluid intake volume was significantly lower(2.23 L ± 0.55 L vs 2.47 L ± 0.56 L, P < 0.001) in the 1.2 L PEG-ASC group than in the PEG-ELS group. Palatability, acceptability of the volume of solution, and overall acceptability evaluated using a patient questionnaire, which was assessed by the visual analog scale, were significantly better in the 1.2 L PEG-ASC group than in the PEG-ELS group(7.70 cm ± 2.57 cm vs 5.80 cm ± 3.24 cm, P < 0.001). No severe adverse event was observed in each group.CONCLUSION The 1.2 L PEG-ASC solution was non-inferior to the 2.0 L PEG-ELS solution in terms of cleansing efficacy and had better acceptability among Japanese patients. 相似文献
8.
聚乙二醇电解质溶液在结肠镜检查前肠道准备中的应用与护理 总被引：14，自引：2，他引：14
目的研究口服聚乙二醇电解质溶液2 000 ml在肠镜检查前肠道准备中的效果和安全性。方法将100例行结肠镜检查的病人随机分为实验组和对照组,实验组口服聚乙二醇电解质溶液清肠,对照组口服电解质溶液加蓖麻油清肠。观察服药后的排便次数和性状,肠道清洁程度,病人服药后的反应,肠腔内气泡情况。服药前、结肠镜检查结束时分别测心率、血压,进行血、尿常规检查和电解质测定。结果实验组肠道准备时间较对照组明显缩短,两组差异有显著意义;两组清洁肠道有效率均达100%,无明显差异;不良反应实验组明显少于对照组;在耐受性方面,实验组优于对照组。结论口服聚乙二醇电解质溶液清洁肠道效果佳,安全性好,可替代我科传统的电解质溶液加蓖麻油清肠方法。 相似文献
9.
10.
目的 探讨肠内营养乳剂辅助饮食管理法在胃癌患者术前肠道准备中的应用.方法 选择2012年6-12月入住上海交通大学医学院附属新华医院的胃癌患者80例,随机分为实验组和对照组各40例.术前肠道准备中,实验组采用肠内营养乳剂(瑞代),对照组采用聚乙二醇,评估两组患者术中肠道清洁程度;观察患者肠道准备期间不良反应与术后肠道功能恢复情况.结果 两组患者术中肠道清洁程度比较,差异无统计学意义(P＞0.05);实验组肠道准备期间出现腹胀、恶心和乏力等不良反应的发生率低于对照组;实验组术后肠道功能恢复较早,两组比较差异有统计学意义(P＜0.05).结论 瑞代用于肠道准备能达到良好的肠道清洁要求,且不良反应少,肠道功能恢复时间早,有助于手术患者的早日康复. 相似文献
11.
目的 比较临床上常用的3种肠道准备方案的肠道清洁效果,寻求最快速有效的肠道准备方案。方法 对2017年5月至6月在江苏省人民医院消化科病房拟行肠镜检查的患者77例行不同方案的肠道准备,并按不同方案分为3组。第1组22例口服聚乙二醇电解质散2 L+乳果糖口服液6包单次服用;第2组31例口服聚乙二醇电解质散2 L+乳果糖口服液6包分次服用;第3组24例口服聚乙二醇电解质散3 L。观察患者服药后肠道准备的效果和不良反应情况。结果 肉眼观察肠道清洁有效的例数,第2组明显多于其他两组（P＜0.05）;肠镜下渥太华量表评分显示,第1组和第2组对比差异无统计学意义（P＞0.05）,第2组和第3组对比,差异有统计学意义（P＜0.05）,说明渥太华评分标准判断下,第2组优于第3组;服药不良反应率比较,第2组明显优于其他两组（P＜0.05）。结论 采用聚乙二醇电解质散2 L+乳果糖口服液6包分次服用方案进行肠道准备,具有较好的肠道清洁效果,不良反应少,患者更易接受。 相似文献
12.
聚乙二醇电解质散剂用于术前肠道准备的安全性与有效性 总被引：5，自引：0，他引：5
目的观察聚乙二醇电解质散剂(舒泰清)在肝胆外科术前肠道准备中的有效性和安全性。方法对50例拟行肝胆外科常规手术的病人,术前一日下午予口服4盒聚乙二醇电解质散剂进行肠道准备,当日晚餐进普食,观察肠道准备的效果;服药后第一日晨及手术当日复查生化,观察其安全性。结果聚乙二醇电解质散剂可以达到满意的清肠效果,未见明显不良反应及电解质改变(P0.05)。结论聚乙二醇电解质散剂用于肝胆外科术前肠道准备安全有效,具有临床使用价值。 相似文献
13.
目的：分析复方聚乙二醇(Polyethylene glycol,PEG)电解质散和20%甘露醇对便秘患者肠道准备的效果和影响因素。方法：选取2015年9月-2016年12月结肠镜诊疗前口服PEG或20%甘露醇的便秘患者,对其肠道准备情况进行分级,并记录患者年龄、性别、便秘病程、平时是否服用促动力药或缓泻剂、肠道准备期间饮食情况、活动情况、耐受情况等。结果：本研究共纳入544例便秘患者,PEG组239例,20%甘露醇组305例。肠道准备总无效率为22.79%,其中PEG组无效率为24.27%,20%甘露醇组无效率为21.64%。便秘病程、平时是否服用促动力药或缓泻剂、肠道准备期间活动情况是PEG在肠道准备无效的影响因素;便秘病程是20%甘露醇在肠道准备无效的影响因素。结论：便秘患者在进行肠道准备时,可对其进行个体化处理,有助于提高肠道准备质量。 相似文献
14.
Fang-Xun Liu Li Wang Wen-Jie Yan Li-Chun Zou Yue-An Cao Xiang-Chun Lin 《World Journal of Clinical Cases》2021,9(15):3586-3596
BACKGROUNDResearch data from patient reports indicate that the least bearable part of colonoscopy is the administration of laxatives for bowel preparation.AIMTo observe the intestinal cleansing efficacy and safety of sodium picosulfate/magnesium citrate and to discuss the patients’ experiences due to the procedure. METHODSSubjects hospitalized in the International Medical Center Ward of Peking University International Hospital, Beijing, China, from April 29 to October 29, 2020, for whom the colonoscopy was planned, were enrolled. Bowel preparation was performed using sodium picosulfate/magnesium citrate. The effect of bowel cleansing was evaluated according to the Ottawa Bowel Preparation Scale, defecation conditions and adverse reactions were recorded, and the comfort level and subjective satisfaction concerning medication were evaluated by the visual analogue scale/score (VAS). RESULTSThe bowel preparation procedure was planned for all patients enrolled, which included 42 males and 22 females. The results showed an average liquid rehydration volume of 3000 mL, an average onset of action for the first dose at 89.04 min, an average number of bowel movements of 4.3 following the first dose, an average onset of action for the second dose at 38.90 min and an average number of bowel movements of 5.0 after the second dose. The total average Ottawa Bowel Preparation Scale score was 3.6, with 93.55% of bowel preparations in the “qualified” and 67.74% in the “excellent” grade. The average VAS score of effect on sleep was 0, and the average VAS score of perianal pain was also 0. The average VAS score for ease of taking and taste perception of the bowel cleanser was 10. Side effects included mild to moderate nausea (15.63%), mild vomiting (4.69%), mild to moderate abdominal pain (7.81%), mild to moderate abdominal distension (20.31%), mild palpitation (7.81%) and mild dizziness (4.69%). CONCLUSIONSodium picosulfate/magnesium citrate is effective and safe for bowel preparation before colonoscopy with high subjective patient acceptance, thus improving overall patient compliance. 相似文献
15.
口服比沙可啶用于小儿结肠镜术前肠道准备 总被引：6，自引：0，他引：6
８８例１８个月至１４岁行纤维结肠镜检查的患儿，采用口服比沙可啶法进行肠道清洁。根据排便习惯按服药方法不同分为３组：服药Ⅰ组、术前晚１次顿服，适于每日排便者；服药Ⅱ组，术前７２ｈ开始服药；服药Ⅲ组，术前９６ｈ开始服药，后两组适于习惯２天或２天以上排便者。３组患儿术前１天进流质。对照组５０例，采用３天饮食控制加灌肠法。结果显示服药组肠道清洁有效率分别为１００％、４６７％、９０６％，Ⅰ组和Ⅲ组显著优于Ⅱ组（Ｐ＜０．０１）；服药组总有效率为８４％，显著优于对照组的７４％（Ｐ＜０．０５）。提示口服比沙可啶法清洁肠道的效果好于灌肠法，每天排便者术前晚１次顿服即可，而排便习惯改变者以术前９６ｈ开始服药效果更佳。应用结果表明，口服比沙可啶法用于小儿肠道准备安全、简便、有效且耐受性良好。 相似文献
16.
目的:分析复方聚乙二醇(Polyethylene Glycol,PEG)电解质散和20%甘露醇对便秘患者肠道准备的效果及影响因素。方法:选取2015年9月~2016年12月结肠镜诊疗前口服肠道清洁剂进行肠道准备的便秘患者544例,按照口服肠道清洁剂的不同分为PEG组239例和20%甘露醇组305例。对两组的肠道准备效果进行分级,并对肠道准备无效的因素进行分析。结果:肠道准备总无效率为22.79%,其中PEG组无效率为24.27%,20%甘露醇组无效率为21.64%,两组的肠道准备效果相比较,差异无统计学意义,P0.05;便秘病程、平时是否服用促动力药或缓泻剂、肠道准备期间活动情况是PEG组肠道准备无效的影响因素;便秘病程是20%甘露醇组肠道准备无效的影响因素。结论:便秘患者在进行肠道准备时,对其进行个体化处理,有助于提高肠道准备的质量和结肠镜诊疗的准确率。 相似文献
17.
Joon Hyun Cho Eun Joo Goo Kyeong Ok Kim Si Hyung Lee Byung Ik Jang Tae Nyeun Kim 《World Journal of Clinical Cases》2019,7(1):39-48
BACKGROUND No consensus has been reached in patients suspected of having inadequate bowel preparation regarding optimal salvage methods, which negatively affects the efficacy and quality of colonoscopy. The most ideal and reasonable rescue option involves early suspicion and identification of patients with inadequate preparation before sedation, additional oral ingestion of a suitable preparation formulation, and same-day colonoscopy.AIM To compare 0.5-L and 1-L polyethylene glycol containing ascorbic acid(PEG +Asc) as additional bowel cleansing methods after a 2-L split-dose PEG + Asc regimen in patients with expected inadequate bowel preparation before colonoscopy.METHODS Individuals with expected inadequate bowel preparation based on last stool form, such as turbid liquid, particulate liquid, or liquid with small amounts of feces, were randomized to either a 0.5-L PEG + Asc group or a 1-L PEG + Asc group. The primary endpoint was bowel preparation as assessed using the Aronchick bowel preparation scale(ABPS) and Boston bowel preparation scale(BBPS) scores. The secondary endpoints were cecal intubation time, withdrawal time, polyp detection rate(PDR), adenoma detection rate(ADR), individual compliance with additional PEG + Asc, and patient satisfaction.RESULTS Initially, 98 patients were included, but 8 were later excluded due to withdrawal of consent to participate in the study. Adequate bowel preparation(as assessed by ABPS) was observed in 80.9%(38/47) of subjects in the 0.5-L group and in88.4%(38/43) of subjects in the 1-L group(P = 0.617). Mean total BBPS was 6.7 points in the 0.5-L group and 7.0 points in the 1-L group(P = 0.458). ADRs and PDRs were similar in the two groups, and cecal intubation and withdrawal times were not significantly different. However, mean patient satisfaction score was significantly higher in the 0.5-L group(P = 0.041).CONCLUSION The bowel cleaning efficacy of additional 0.5-L PEG + Asc was not inferior to that of 1-L PEG + Asc. Additional 0.5-L PEG + Asc is worthwhile when inadequate bowel preparation is expected before colonoscopy. 相似文献
18.
目的 探讨妇科择期手术术前肠道准备中提高肠道清洁率、减轻病人痛苦,术后肠蠕动尽快恢复的方法.方法 对2011年收治的358例妇科择期手术病人,按手术时间的单双号分为观察组和对照组,观察组患者采用磷酸钠盐口服液加番泻叶进行围手术期肠道准备,对照组患者口服聚乙二醇电解质溶液进行围手术期肠道准备.结果 观察组患者的肠道清洁度、不良反应、排便次数、术后排气情况等均好于对照组,差异有极显著意义(P＜0.01).结论 磷酸钠盐口服液加番泻叶溶液口感好,肠道清洁度高,排便次数减少,术后排气早、无腹胀、肠道功能恢复早,其效果优于单纯口服聚乙二醇电解质溶液. 相似文献
19.
聚乙二醇电解质散在结肠镜检查前肠道准备中的应用 总被引：24，自引：0，他引：24
目的 :探讨聚乙二醇电解质散在结肠镜检查前肠道准备中的效果和安全性。方法 :4 4例接受结肠镜检查的病人随机分为A组和B组 ,A组口服聚乙二醇电解质散 ,B组口服Niflec。观察服药过程中排便情况 ,肠腔清洗效果和气泡存在情况。服药前和结肠镜检查结束后分别进行血尿常规、肝肾功能检查和电解质测定。结果 :两组病人在服药后约 1～ 1.5h开始排便 ,排便 3～ 5次后即可接受肠镜检查 ,清洁肠道的有效率均为10 0 % ,无 1例出现恶心、呕吐、腹痛和头痛等不良反应。两组在排便时间 ,肠腔清洗效果和实验室指标变化间比较均无显著差异。结论 :聚乙二醇电解质散应用于结肠镜检查前的肠道准备安全有效 ,准备时间短 ,不需要饮食限制 ,值得临床推广应用 相似文献
20.
目的：探讨提高结肠镜检查肠道准备效果的方法。方法：观察组检查前3d服西沙必利5mg,3次／d,检查前晚服50％硫酸镁溶液90ml,对照组不服西沙必利,肠道清洁度差者,开塞露2支注入直肠,排便后作结肠镜。结果：观察组205例,对照组206例,清洁者55．1％和20．9％,良好28．3％和19．4％,尚可13．7％和34．9％,差2．9和24．8％,插镜达盲肠或回肠末端者70．7％和58．7％,32例使用开塞露者,清洁65．5％,良好28．1％,结论：西沙必利对结肠镜检查肠准备有良好的促进作用,开塞露是肠道清洁度差者理想的补救方法。 相似文献
